Headquartered in Ankara, Türkiye, Burgeon is engaged in the development and production of medical aesthetic products, focusing on solutions such as dermal fillers.

Diffusion Capital Partners, is a Türkiye-based venture capital firm investing in early-stage technology and innovation-driven companies. The firm had been a partner in Burgeon since Burgeon’s founding in 2017.

With this transaction, VIVACY, a global reference point in the field of medical aesthetics and dermal filler products, will become a strategic partner of Burgeon; while Burgeon will have the opportunity to make a strategic leap in terms of product development, production infrastructure and access to international markets.